Metabolic biomarkers for predicting cardiovascular disease
Jana E Montgomery1, Jeremiah R Brown
1Dartmouth-Hitchcock Medical Center, Division of Cardiology, Lebanon, NH 03756, USA. jana.e.montgomery@hitchcock.org
Vascular Health and Risk Management
|February 7, 2013
Summary
Understanding cardiovascular biomarkers is crucial for preventing heart disease and reducing healthcare costs. This paper explores their definition, clinical use, and the approval process for biomarkers like high-sensitivity C-reactive protein.
Area of Science:
- Biomarkers
- Cardiovascular Medicine
- Health Economics
Background:
- Cardiovascular disease (CVD) represents a significant economic burden, exceeding 20% of US healthcare costs as of 2008.
- Increasing financial pressures necessitate proactive strategies for cardiovascular disease prevention.
- Identifying individuals at risk for cardiovascular events is paramount for effective intervention.
Purpose of the Study:
- To discuss the societal costs associated with cardiovascular disease.
- To clarify the definition and importance of biomarkers in clinical practice.
- To examine the regulatory pathway for the clinical adoption of novel biomarkers.
Main Methods:
- Literature review on cardiovascular disease costs and biomarker utility.
- Definition and explanation of biomarker concepts.
- Case study of high-sensitivity C-reactive protein as a current biomarker.
- Analysis of the biomarker approval process for clinical use.
Main Results:
- Cardiovascular disease incurs substantial economic costs.
- Biomarkers are essential tools for risk stratification and early detection.
- High-sensitivity C-reactive protein serves as a validated cardiovascular biomarker.
- The approval process for clinical biomarkers involves rigorous evaluation.
Conclusions:
- Effective utilization of cardiovascular biomarkers can aid in preventing adverse events.
- Understanding biomarker development and approval is key to advancing cardiovascular care.
- Biomarker research and implementation are vital for managing the economic impact of cardiovascular disease.
Related Concept Videos
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:30Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...